Tukysa Europska Unija - hrvatski - EMA (European Medicines Agency)

tukysa

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastična sredstva - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

Kymriah Europska Unija - hrvatski - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastični agensi - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

REAGENSI I KONTROLNI REAGENSI U IMUNOHEMATOLOGIJI Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

reagensi i kontrolni reagensi u imunohematologiji

inel - medicinska tehnika d.o.o., zagreb - reagensi i kontrolni reagensi za određivanje različitih sustava krvnih grupa

REAGENSI, KALIBRATORI I KONTROLNI MATERIJALI ZA ODREĐIVANJE HEPATITISA Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

reagensi, kalibratori i kontrolni materijali za odreĐivanje hepatitisa

meditrade h d.o.o., zagreb - reagensi, kalibratori i kontrolni materijali za detekciju, potvrdu i kvantifikaciju markera hepatitisa